Internal Medicine · 2000 · 27 citations · 13 references
MedicineEndocrinologyInternal MedicineAutoimmunityClinical ImmunologyDiabetologyAutoimmune DiseasesDiabetes ControlDiabetes ManagementDiabetes MellitusInsulin TherapyInterferon-based TherapyBlood Glucose RegulationDiabetes-related ComplicationsGlucose-stimulated Insulin SecretionIntensive Insulin TherapyInterferon Alfa TherapyType 1 Diabetes Pathophysiology
A 57-year-old man was referred to our outpatient clinic after interferon-beta (IFN-beta) treatment for 7 weeks. While IFN-beta therapy was continued in our outpatient clinic, his blood glucose level increased gradually, and he was admitted to our hospital for hyperglycemia. The patient was prescribed a 1,600-kcal diet and intensive insulin therapy was performed. GAD antibody became positive 15 months after the start of IFN therapy, and disappeared 27 months after the start of IFN therapy. Insulin secretion was depleted and the patient had HLA-DR4, B54, and DRB1*0405. This appears to be a case of type 1 diabetes mellitus induced by administration of IFN-beta alone.
13
Side effects of high-dose interferon therapy for chronic hepatitis C
T Okanoue, Shinichi Sakamoto, Yoshito Itoh et al. · Journal of Hepatology · 1996 · 463 citations
64 000 Mr autoantibodies as predictors of insulin-dependent diabetes
Mark A. Atkinson, Noel K. Maclaren, William J. Riley et al. · The Lancet · 1990 · 208 citations
William Hagopian, Allan E. Karlsen, Anders Gottsäter et al. · Journal of Clinical Investigation · 1993 · 200 citations · Full text
Effect of Interferon on Glucose Tolerance and Insulin Sensitivity
Veikko A Koivisto, Risto Pelkonen, Kari Cantell · Diabetes · 1989 · 151 citations
Medicine, Endocrinology, Immunology +14